Glez Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Gwalior, Madhya Pradesh, India, established in 2020.
2020 Gwalior, Madhya Pradesh, India Active
Last Updated:
Access Report
About Glez Pharmaceuticals Private Limited

Glez Pharmaceuticals Private Limited, a active private limited company, was established on 30 March 2020 in Gwalior, Madhya Pradesh, India. Engaging in wholesale within the business services sector, it holds CIN: U51100MP2020PTC051229. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.

Its leadership includes Ved Prakash Jha (Managing Director), Tejaswini Patil (Whole-Time Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2022. It is based at N/4 Govardhan Apartment, 24 Beegha Vinay Nagar, Lashkar, Gwalior, Madhya Pradesh, 474012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51100MP2020PTC051229

  • Registration Number

    051229

  • Incorporation Date

    30 March 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 5 Year, 10 Months
  • Last Filing with ROC 31 Mar 2022
Company report

Glez Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Glez Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Glez Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ved Prakash Jha Managing Director 30 Mar 2020 Current
Tejaswini Patil Whole-Time Director 30 Mar 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Glez Pharmaceuticals.

Enhance accessibility to Glez Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Glez Pharmaceuticals revenue growth over time
Glez Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Glez Pharmaceuticals?

Unlock access to Glez Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Glez Pharmaceuticals?

Unlock and access historical data on people associated with Glez Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Glez Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glez Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Glez Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Glez Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Glez Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Gwalior. was completed.

  • Director Appointment

    Progress on Ved Prakash Jha was appointed as a Managing Director was appointed as a Managing Director on 30 Mar 2020 & has been associated with this company since 5 years 10 months . was documented.

  • Director Appointment

    The activity Tejaswini Patil was appointed as a Whole-time director was appointed as a Whole-time director on 30 Mar 2020 & has been associated with this company since 5 years 10 months . was completed.

  • Company Incorporation

    The activity Glez Pharmaceuticals Private Limited was registered on 30 Mar 2020 with Roc Gwalior & aged 5 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Glez Pharmaceuticals Private Limited?

The CIN of Glez Pharmaceuticals Private Limited is U51100MP2020PTC051229.

Where is Glez Pharmaceuticals Private Limited headquartered?

Glez Pharmaceuticals Private Limited is headquartered at N/4 Govardhan Apartment, 24 Beegha Vinay Nagar, Lashkar, Gwalior, Madhya Pradesh, 474012.

When was Glez Pharmaceuticals Private Limited incorporated?

Glez Pharmaceuticals Private Limited was incorporated on 30 March 2020.

Who are the current directors of Glez Pharmaceuticals Private Limited?

The current directors of Glez Pharmaceuticals Private Limited are

What is the primary industry of Glez Pharmaceuticals Private Limited?

The primary industry of Glez Pharmaceuticals Private Limited is Business Services.

Is Glez Pharmaceuticals Private Limited a listed company?

Glez Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Glez Pharmaceuticals Private Limited?

The authorized capital of Glez Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available